Skinbiotherapeutics Share Discussion Threads

[riskybusiness1] 13/4/2018 14:34

Opportunity to buy at IPO price or below has now gone imo. Next 12 months will see some great science translated in to commercial interest. Last RNS shows the corporate interest even before human studies. Science is clearly well sought after. People just need to be aware of how long it takes to build a business which relies on license deals. Patience will make a lot of money for people here and with Opti (even from 700% up from IPO 3 years ago... things are just beginning commercially over there)

[onedayrodders] 13/4/2018 14:12

WOW instant arbitrage on current quote !

9.50 offer 10.00 bid

[parob] 13/4/2018 13:03

A small top up for me today. Surprised this hasn't moved up yet based on all the buying. Hoping 9.75p is the higher low going in.

[bobalot] 12/4/2018 15:32

What is a "cosmeceutical", The American FDA won't need SBTX to get medical drug approval which means deployment will be faster once the medical creams etc have been developed.

The term "cosmeceutical" is often used in cosmetic advertising and may be misleading to the consumer. If the consumer interprets a cosmeceutical to be similar to a pharmaceutical product, he or she may conclude that cosmeceuticals are required to undergo the same testing for efficacy and quality control as required for medication. This may allow the retailer to charge the consumer more for a product which may actually be less effective and/or of poorer quality than perceived.[4]

However, according to the United States Food and Drug Administration (FDA), the Food, Drug, and Cosmetic Act "does not recognize any such category as "cosmeceuticals". A product can be a drug, a cosmetic, or a combination of both, but the term "cosmeceutical" has no meaning under the law".[5]

Additionally, the FDA states that: "Food, Drug and Cosmetic Act defines drugs as those products that cure, treat, mitigate or prevent disease or that affect the structure or function of the human body. While drugs are subject to an intensive review and approval process by FDA, cosmetics are not approved by FDA prior to sale. If a product has drug properties, it must be approved as a drug."[6]

[bobalot] 12/4/2018 15:17

Here are some insights into the huge Korean Skincare market, ripe and ready for SBTX technology:

Beyond beauty: Korean makeup provides 'cosmeceuticals'
By Marian Liu, CNN

Updated 0028 GMT (0828 HKT) April 12, 2018

The Korean beauty market is among the top 10 around the world, with an estimated worth of over $13.1 billion in sales in 2018, according to Mintel, a global market intelligence agency.

Facial skin care products alone make up half of the total market share and are projected to reach $7.2 billion by 2020. And one in five facial skin care launches in South Korea, the agency reports, is actually a mask.

[elrico] 11/4/2018 11:16

Pro- and prebiotics on the skin? An interview with Dr. Cath O’Neill

[bobalot] 11/4/2018 10:32

For what it's worth here is what British bulls indicates:

Signal Update Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 06/04/2018, 4 days ago, when the stock price was 8.5250. Since then SBTX.L has risen by +18.48%.Market Outlook You may relax since our STAY LONG position is secure. The market action does not cast a serious doubt on the wisdom of going long.

[parob] 10/4/2018 22:34

3 month closing high.

[shrewdmole] 10/4/2018 22:24

Broke the ceiling so should see further gains

[elrico] 10/4/2018 17:03

Chart looking much better

[bobalot] 10/4/2018 11:06

They have done all the testing on live skin in the lab which is a really reliable test model prior to field tests which will only take a month before commercialisation starts apace.

[shrewdmole] 10/4/2018 10:57

Rathean

I think this is still way below many peoples radar.

We've seen what can happen with stocks like this n4p is a great example.

Let's not forget although we are waiting for human trials the testing to date has been on human skin samples I believe and with great results.

The risk reward here is phenomenal.

S

[semper vigilans] 10/4/2018 09:34

Hope you are right Rathean!

[rathean] 10/4/2018 09:21

Early buying today pushing the price up, of all my riskier plays with human trials due and a pre-commercial agreement in place the risk reward here is very attractive imo.

[bobalot] 09/4/2018 10:57

The cancer research at Cardiff Uni shows a lot of promise:



Julian Marchesi, professor of human microbiome research at Cardiff University who was not involved in the study, welcomed the findings.

“[This research] further adds to a growing understanding of how important the human microbiota, and in this case the skin microbiome, is to health. We have evolved to need these microbes and desperately need to understand all the roles they play in human biology and start to think more about what it is to be a human being,” he said. “The next stage of this exciting work, will be to translate it to human clinical trials and show that this bacterially produced chemical can protect the host from skin cancers.”

[elrico] 08/4/2018 18:55

Cath commented on the guardian article. SBTX don't appear to be looking in this particular direction at this stage.

"Yes it is interesting isn’t it. I know Rich Gallo, the scientist behind this work very well. He always does really cool studies. However, for now, its important to remember that the work has been done in mice. Its quite a big leap from a mouse to human but nevertheless, really intriguing as you say."

[loungeact] 07/4/2018 16:55

"People are buying into this based on the technology and highly likely longer term multi-bag rises expected later...the company have said that many corporates have approached the business.."

sounds very much like OPTI too.

[bobalot] 06/4/2018 18:23

People are buying into this based on the technology and highly likely longer term multi-bag rises expected later...the company have said that many corporates have approached the business and that the CEO has no problems being invited to boardrooms for discussions.


IN THE BACKGROUND THIS SECTOR HAS PLENTY OF TAKERS FOR SKINBIO INNOVATIONS meaning more deals will unfold going forward IMO.

[onedayrodders] 06/4/2018 14:40

New ISA buying I guess today

[rathean] 06/4/2018 12:13

Up 16% on the day, starting to form a quite steep rising trend... early days but we might see an N4P effect.

[parob] 06/4/2018 11:48

Skinbiotherapeutics PLC Q&A: MTA with Global Consumer Goods Company (LON:SBTX)

Posted by: Amilia Stone 5th April 2018

Skinbiotherapeutics PLC (LON:SBTX) Chief Executive Officer Dr Cath O’Neill caught up with DirectorsTalk for an exclusive interview to discuss the signing of an MTA with a global consumer goods company

Q1: Cath, yesterday you announced a signing of a Materials Transfer Agreement with a global consumer goods company, can you tell us what does the MTA mean?

A1: So, the Materials Transfer Agreement basically means that we, as a company, have agreed to hand over some of our technology to this other company so that they can run it through some tests and work on it themselves, the material refers to the technology. So, that’s basically what it is in a nutshell.

Q2: What does this mean then for Skinbiotherapeutics?

A2: Well, I think what it signals is that the ‘big boys’ in the consumer goods space are sitting up and taking notice of us, it’s not every day that a global giant spends its time testing the technology of a little tiny company like Skinbiotherapeutics. So, I think it’s a test to the quality of our research data, our science and the fact that they are sitting up and taking notice of us now.

[shrewdmole] 06/4/2018 11:16

I've said it before but I believe a commercial tie up will come before human trials as j and j will want to have input into those trials IMHO.